Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:7-9
doi: 10.1161/01.ATV.0000153086.46231.8c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fazio, S.
Right arrow Articles by Linton, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fazio, S.
Right arrow Articles by Linton, M. F.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:7.)
© 2005 American Heart Association, Inc.


Editorials

ACAT Inhibition

Bad for Macrophages, Good for Smooth Muscle Cells?

Sergio Fazio; Dwayne E. Dove; MacRae F. Linton

From the Department of Pathology (S.F., D.E.D.), Department of Medicine, Division of Cardiovascular Medicine (S.F., M.F.L.), and Department of Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn.

Correspondence to Sergio Fazio, Vanderbilt University Medical Center, Division of Cardiovascular Medicine, 383 Preston Research Building, Nashville, TN 37232-6300. E-mail sergio.fazio@vanderbilt.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Ahallmark of the atherosclerotic plaque is the accumulation of lipid-laden foam cells that are derived from macrophages or smooth muscle cells (SMCs).1,2 Cholesterol from modified lipoproteins is taken up and either stored in intracellular lipid droplets or delivered to extracellular cholesterol acceptors. Cellular free cholesterol can be exported to nascent HDL and activate the reverse cholesterol transport system, but when it accumulates in large amounts it can induce toxic changes leading to cell death. Conversely, esterified cholesterol is a more inert form of cholesterol for storage, but is not available for efflux to extracellular cholesterol acceptors. Acyl-coenzyme A (CoA): cholesterol acyltransferase (ACAT) esterifies excess free cholesterol and regulates cellular cholesterol homeostasis. ACAT occurs in two isoforms, ACAT-1 and ACAT-2. Whereas liver and intestine express both ACAT-1 and ACAT-2, macrophages and SMCs express ACAT-1 only.3 Nonselective inhibition of ACAT has the potential to both lower plasma lipids and to reduce foam cell formation.3,4 However, the therapeutic potential of ACAT inhibitors is not without controversy, because data have been published suggesting beneficial effects on experimental atherosclerosis as well as negative effects on macrophage viability.5–7 Furthermore, elimination of macrophage ACAT-1 is associated with increased atherosclerotic lesion formation in murine models.8 In this issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Rong et al point to SMCs as a possible explanation for the apparently contradictory effects of ACAT inhibition.9

See page 122

In this study, Rong et al confirm the role of ACAT-1 in the formation of SMC foam cells and show that SMCs . . . [Full Text of this Article]


Related Article:

Acyl-CoenzymeA (CoA):Cholesterol Acyltransferase Inhibition in Rat and Human Aortic Smooth Muscle Cells Is Nontoxic and Retards Foam Cell Formation
James X. Rong, Jun Kusunoki, Peter Oelkers, Stephen L. Sturley, and Edward A. Fisher
Arterioscler Thromb Vasc Biol 2005 25: 122-127. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Murphy, G. S. Kanaganayagam, B. Jiang, P. J. Chowienczyk, R. Zbinden, M. Saha, S. Rahman, A. M. Shah, M. S. Marber, and M. T. Kearney
Vascular Dysfunction and Reduced Circulating Endothelial Progenitor Cells in Young Healthy UK South Asian Men
Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 936 - 942.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. L. Rudel, R. G. Lee, and P. Parini
ACAT2 Is a Target for Treatment of Coronary Heart Disease Associated With Hypercholesterolemia
Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1112 - 1118.
[Abstract] [Full Text] [PDF]